Evaluation of microRNA‐10a and microRNA‐210 as Biomarkers in Sepsis Patients With Acute Kidney Injury
International Journal of Nephrology · 2024-01 · 2024 (1)
DOI: 10.1155/ijne/1555811 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nephrology, online erschienen am 11.12.2024. Verfasst von Hani Susianti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pathology Department, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitas Brawijaya.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis‐associated acute kidney injury (AKI) is a condition that increases in‐hospital mortality and the risk of progression to CKD. The current method of detecting AKI, which relies on increased serum creatinine levels or a decrease in urine output, has low sensitivity. Early diagnosis and appropriate intervention in AKI can lead to improved patient outcomes. Several low molecular weight proteins and microRNAs detected in AKI are considered early biomarkers of AKI, such as miR‐10a‐5p and miR‐210‐3p.
Method
A cross‐sectional study was conducted among 62 participants, consisting of 26 sepsis patients with AKI, 26 sepsis patients without AKI, and 10 healthy controls. AKI was determined according to KDIGO criteria. MicroRNA expression was analyzed using reverse transcription quantitative polymerase chain reaction (RT‐qPCR). Statistical analysis was obtained using the Kruskal–Wallis test, Spearman’s correlation coefficient, and ROC curve analysis.
Result
The median miR‐10a‐5p expression of the healthy controls versus sepsis with AKI versus sepsis without AKI groups was 10.38 (5.50–33.82) versus 10.32 (3.32–31.53) versus 9.76 (0.32–97.36), while the median miR‐210‐3p expression was 0.20 (0.03–0.41) versus 0.38 (0.04–1.24) versus 0.29 (0.06–1.67), respectively, with p = 0.721 for miR‐10a‐5p and p = 0.013 for miR‐210‐3 p. A significant increase in miR‐210‐3p expression was found in the sepsis with AKI compared to the healthy controls ( p = 0.013) and sepsis without AKI ( p = 0.034). miR‐210‐3p significantly correlated with creatinine and urea serum level ( p < 0.05); miR‐10a‐5p did not have a significant correlation. The sensitivity and specificity of miR‐10a‐5p were 61.5% and 47.2%, and miR‐210‐3p were 84.6% and 63.9% for determining AKI.
Conclusion
The study’s findings revealed a significant increase in miR‐210‐3p expression in sepsis patients with AKI, indicating its potential as a promising biomarker for determining AKI. This discovery demonstrates that the diagnostic performance of miR‐210‐3p surpasses that of miR‐10a‐5p, providing a more accurate biomarker for diagnosing AKI in sepsis patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Pathology Department, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
- Central Laboratory Department, RSUD Dr. Saiful Anwar, Malang, Indonesia.
ORCID-Profile: Hani Susianti, Catur Suci Sutrisnani, I P Adi Santosa, Wahyu Febrianto, Amanda Yuanita Kusdjianto, Kevin Putro Kuwoyo, Elita Riyu
Förderung
- Universitas Brawijaya
Zitieren
APA
Susianti, H., Sutrisnani, C. S., Santosa, I. P. A., Febrianto, W., Kusdjianto, A. Y., Kuwoyo, K. P., & Riyu, E. (2024). Evaluation of microRNA‐10a and microRNA‐210 as Biomarkers in Sepsis Patients With Acute Kidney Injury. International Journal of Nephrology, 2024(1). https://doi.org/10.1155/ijne/1555811
Vancouver
Susianti H, Sutrisnani CS, Santosa IPA, Febrianto W, Kusdjianto AY, Kuwoyo KP, et al. Evaluation of microRNA‐10a and microRNA‐210 as Biomarkers in Sepsis Patients With Acute Kidney Injury. International Journal of Nephrology. 2024;2024(1). doi:10.1155/ijne/1555811
BibTeX
@article{Susianti2024,
author = {Susianti, Hani and Sutrisnani, Catur Suci and Santosa, I P Adi and Febrianto, Wahyu and Kusdjianto, Amanda Yuanita and Kuwoyo, Kevin Putro and Riyu, Elita},
title = {Evaluation of microRNA‐10a and microRNA‐210 as Biomarkers in Sepsis Patients With Acute Kidney Injury},
journal = {International Journal of Nephrology},
year = {2024},
volume = {2024},
number = {1},
doi = {10.1155/ijne/1555811}
}
EUVIMED